Mustafa B A Djamgoz (Mustafa Djamgoz)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Topics

Squamous Cell Carcinoma

Radical Prostatectomy

Angiotensin Converting Enzyme

Top Venues

British journal of cancer

The Journal of membrane biology

Basic & clinical pharmacology & toxicology

The EMBO journal

This page only lists publications with an associated author ORCID identifier.

Publications

Mustafa B A Djamgoz
Ranolazine: a potential anti-metastatic drug targeting voltage-gated sodium channels. British journal of cancer 130 (9) (2024)
Nahit Rizaner, Scott P Fraser, Ilknur Bugan Gul, Esma Purut, Mustafa B A Djamgoz, Seyhan Altun
Lidocaine Inhibits Rat Prostate Cancer Cell Invasiveness and Voltage-Gated Sodium Channel Expression in Plasma Membrane. The Journal of membrane biology 257 (1-2) (2024)
Mustafa B A Djamgoz
Ranolazine: a potential anti-metastatic drug targeting voltage-gated sodium channels. British journal of cancer (2024)
Nahit Rizaner, Scott P Fraser, Ilknur Bugan Gul, Esma Purut, Mustafa B A Djamgoz, Seyhan Altun
Lidocaine Inhibits Rat Prostate Cancer Cell Invasiveness and Voltage-Gated Sodium Channel Expression in Plasma Membrane. The Journal of membrane biology (2024)
Mustafa B A Djamgoz
Ranolazine: a potential anti-metastatic drug targeting voltage-gated sodium channels. British journal of cancer 130 (9) (2024)
Mustafa B A Djamgoz
Electrical excitability of cancer cells-CELEX model updated. Cancer metastasis reviews (2024)
Mustafa B A Djamgoz
Ranolazine: a potential anti-metastatic drug targeting voltage-gated sodium channels. British journal of cancer (2024)
Mustafa B A Djamgoz
Ranolazine: a potential anti-metastatic drug targeting voltage-gated sodium channels. British journal of cancer 130 (9) (2024)
Nahit Rizaner, Scott P Fraser, Ilknur Bugan Gul, Esma Purut, Mustafa B A Djamgoz, Seyhan Altun
Lidocaine Inhibits Rat Prostate Cancer Cell Invasiveness and Voltage-Gated Sodium Channel Expression in Plasma Membrane. The Journal of membrane biology 257 (1-2) (2024)
Mustafa B A Djamgoz
Ranolazine: a potential anti-metastatic drug targeting voltage-gated sodium channels. British journal of cancer 130 (9) (2024)
Antoine Folcher, Dmitri Gordienko, Oksana Iamshanova, Alexandre Bokhobza, George Shapovalov, Dheeraj Kannancheri-Puthooru, Pascal Mariot, Laurent Allart, Emilie Desruelles, Corentin Spriet, Raquel Diez, Thibauld Oullier, Séverine Marionneau-Lambot, Lucie Brisson, Sandra Geraci, Hathaichanok Impheng, V'yacheslav Lehen'kyi, Aurélien Haustrate, Adriana Mihalache, Pierre Gosset, Stéphanie Chadet, Stéphanie Retif, Maryline Laube, Julien Sobilo, Stéphanie Lerondel, Giulia Villari, Guido Serini, Alessandra Fiorio Pla, Sébastien Roger, Gaelle Fromont-Hankard, Mustafa B A Djamgoz, Philippe Clezardin, Arnaud Monteil, Natalia Prevarskaya
NALCN-mediated sodium influx confers metastatic prostate cancer cell invasiveness. The EMBO journal (2023)
Mustafa B A Djamgoz
Combinatorial Therapy of Cancer: Possible Advantages of Involving Modulators of Ionic Mechanisms. Cancers 14 (11) (2022)
Shiwen Qiu, Scott P Fraser, Wayne Pires, Mustafa B A Djamgoz
Anti-invasive effects of minoxidil on human breast cancer cells: combination with ranolazine. Clinical & experimental metastasis 39 (4) (2022)
Mustafa B A Djamgoz
Comments on: Antiepileptic drugs and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer. International journal of cancer (2021)
Nahit Rizaner, Sercan Uzun, Scott P Fraser, Mustafa B A Djamgoz, Seyhan Altun
Riluzole: Anti-invasive effects on rat prostate cancer cells under normoxic and hypoxic conditions. Basic & clinical pharmacology & toxicology 127 (4) (2020)